These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 13130490)

  • 1. Interpretation of trial methodology not always easy: comment on the editorial by Landewé.
    Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2003 Sep; 48(9):2693-4; author reply 2695. PubMed ID: 13130490
    [No Abstract]   [Full Text] [Related]  

  • 2. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comment on R. Rau: "A not only American controversy on the effectiveness of parenteral gold treatment"].
    Tillmann K
    Z Rheumatol; 1994; 53(5):317-8. PubMed ID: 7810241
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levamisole used in rheumatoid arthritis].
    Veys EM; Mielants H
    Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials: how to cope with medical needs, ethics and timelines.
    Rubbert-Roth A; Burmester GR
    Ann Rheum Dis; 2010 Jan; 69(1):1-3. PubMed ID: 20007619
    [No Abstract]   [Full Text] [Related]  

  • 7. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reconsideration of glucocorticoid therapy for rheumatoid arthritis].
    Ichikawa Y
    Ryumachi; 2002 Dec; 42(6):859-62. PubMed ID: 12632604
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evidence for low-dosage prednisolone in early rheumatoid arthritis. Prevents destruction of the joints and relieves symptoms].
    Svensson B; Hafström I
    Lakartidningen; 2006 Nov 22-28; 103(47):3704-9. PubMed ID: 17212318
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reumacon--licensed drug of widespread use].
    Lerndal T; Svensson B
    Lakartidningen; 2001 Feb; 98(7):684-5. PubMed ID: 11475258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early therapy -- later retirement].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):6, 8. PubMed ID: 15887692
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.
    Wolfe F; Michaud K
    Rheumatology (Oxford); 2005 Dec; 44 Suppl 4():iv18-iv22. PubMed ID: 16306476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterpoint from the trenches: a pragmatic approach to therapeutic trials in rheumatoid arthritis.
    Strand V
    Arthritis Rheum; 2004 Apr; 50(4):1344-7. PubMed ID: 15077319
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years).
    McLaren ZL; Abernethy VE; Dawson JK
    Rheumatology (Oxford); 2009 Sep; 48(9):1178-9; author reply 1179. PubMed ID: 19578135
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefit-risk analysis: examples using quantitative methods.
    Holden WL; Juhaeri J; Dai W
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):693-7. PubMed ID: 14762986
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the STAR trial really a safety trial?
    Yazici H
    J Rheumatol; 2004 Dec; 31(12):2528; author reply 2528-9. PubMed ID: 15570666
    [No Abstract]   [Full Text] [Related]  

  • 17. Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.
    Kingsley GH; Khoshaba B; Smith CM; Choy EH; Scott DL
    Rheumatology (Oxford); 2005 May; 44(5):629-32. PubMed ID: 15705630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should contemporary rheumatoid arthritis clinical trials be more like standard patient care and vice versa?
    Pincus T; Sokka T
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii32-ii39. PubMed ID: 15479869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational cohort studies and well controlled clinical trials--we need them both!
    Furst DE
    J Rheumatol; 2004 Aug; 31(8):1476-7. PubMed ID: 15290723
    [No Abstract]   [Full Text] [Related]  

  • 20. [When to begin rheumatism treatment? Initial combination therapy helps fastest].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):5-6. PubMed ID: 15887691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.